Efficacy and Tolerability of Reboxetine in Depressive Patients Treated in Routine Clinical Practice

By Thomas Messer  

CNS Drugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 43-54

Adis International

Access to resources Recommend Favorite

A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease

By Bonuccelli Ubaldo   Meco Giuseppe   Fabbrini Giovanni   Tessitore Alessandro   Pierantozzi Mariangela   Stocchi Fabrizio   Ceravolo Roberto   Caltagirone Carlo   Silvestrini Mauro   Morgante Francesca   Ruggieri Stefano   Avanzino Laura   Guadagna Michele   Dell'Agnello Grazia   Rossi Andrea   Spezia Riccardo   Mancini Michele  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2269-2280

Informa Healthcare

Access to resources Recommend Favorite

Clinical pharmacology review of escitalopram for the treatment of depression

By Pastoor Devin   Gobburu Joga  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 1, 2014-01 ,pp. : 121-128

Informa Healthcare

Access to resources Recommend Favorite

Clinical Features and Efficacy of Escitalopram Treatment for Geriatric Depression

By Chen Y-M   Huang X-M   Thompson R   Zhao Y-B  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1946-1953

Field House Publishing

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H.   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite